All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Participants

This research is testing a new medicine called Mevrometostat. It's an early-stage study, specifically looking at how different ways of giving this medicine (different 'formulations') are taken up into the blood of healthy adult volunteers. This kind of study helps researchers understand how the body handles the medicine. While the medicine is being explored for conditions like specific types of lung cancer, prostate cancer, and a type of lymphoma, this particular study is focused on healthy people to get basic information about its absorption. It's a key step in developing potential new treatments for these conditions, ensuring the medicine is absorbed effectively and safely by the body.

At a glance

Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- Other
Sponsor
Pfizer Inc.
Enrolment target
16
Start
19 Nov 2024

What is this study about?

This study is about a new medicine called Mevrometostat. When doctors are developing new medicines, they need to understand how the body uses them. One very important part of this is knowing how the medicine gets from where it's given (for example, a tablet you swallow) into your bloodstream. This is called 'absorption'. Every medicine is made in a specific way, and sometimes small changes in how it's made can affect how well it's absorbed.

This particular study is focusing on something called "different formulations" of Mevrometostat. Imagine a medicine can be made in a slightly different way, perhaps as a different type of tablet or capsule. Researchers want to see if these different ways of making the medicine change how quickly or how much of it gets into your blood. This is a very early step in drug development, and it helps scientists choose the best way to give the medicine to patients in the future.

Although Mevrometostat is being looked at as a potential treatment for certain serious conditions like a type of lung cancer (small cell lung cancer), a type of prostate cancer that has become resistant to usual treatments (castration-resistant prostate cancer), and a type of blood cancer (follicular lymphoma), this study isn't actually testing it in people with these illnesses. Instead, it's being given to healthy adult volunteers. This allows researchers to get clear information about how the healthy body absorbs the medicine without other health conditions affecting the results. It's all about gathering foundational knowledge to help develop this medicine for those who might need it one day.

Key takeaways

  • This study tests how a new medicine, Mevrometostat, is absorbed by the body.
  • It involves healthy adult volunteers, not people with cancer.
  • The goal is to understand how different forms of the medicine get into the blood.
  • This is an early but crucial step in developing new cancer treatments.
  • Participation involves clinic visits, blood tests, and health checks.
  • You won't directly benefit from the medicine, but you'll help medical research.

Who may be eligible?

To be able to take part in this research, you need to be a healthy adult. This means you must be 18 years old or older, with no upper age limit, and you can be a man or a woman.

Because this study is about how the body absorbs the medicine, it's important that participants are generally in good health. This helps the researchers get a clear picture of how Mevrometostat works in a typical, healthy person, without other health issues confusing the results.

The study will have more specific health checks to make sure it's safe for you to take part. For example, they will likely look at your general health, any medicines you're currently taking (even over-the-counter ones), and perhaps your family medical history. These checks are always done to protect your safety.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 18 years old or older?
  2. Are you generally in good health?
  3. Are you willing to attend regular clinic appointments?
  4. Are you comfortable with having blood samples taken?
  5. Are you able to follow specific instructions about diet or other activities during the study?
Answer every question to see your result.

What does participation involve?

Taking part in this study would involve a series of visits to a clinic. You would be given the experimental medicine, Mevrometostat, likely in different forms on different occasions, to see how your body reacts. During these visits, medical staff would regularly take blood samples to measure how much of the medicine is in your bloodstream over time. You would also have regular health checks, which might include having your blood pressure taken, heart rate monitored, and general physical examinations. The exact number of visits, how long each visit lasts, and the total duration of your participation would be fully explained before you agree to join. There will be specific instructions about what you can and cannot eat or do before and during certain study periods. There would also be follow-up appointments after you take the last dose of the medicine to ensure you are well.

Potential risks and benefits

Potential benefits for participants in this study are indirect; you would be helping advance medical research that could one day lead to new treatments for serious illnesses. There are no direct health benefits expected for you. Potential risks could include side effects from the study medicine, which would be explained in detail, and discomfort from procedures like regular blood tests. Your safety is paramount, and you would be closely monitored throughout. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Unverified
    Belgium

Common questions

What is Mevrometostat?

Mevrometostat is a new medicine being studied. This research specifically looks at how your body absorbs it.

Am I helping people with cancer by joining this study?

Yes, indirectly. This early research provides vital information to help develop potential future treatments for certain cancers like lung, prostate, and lymphoma.

Will I get sick from the medicine?

All medicines can have side effects. You would be told about all known or possible side effects, and your health would be carefully watched by doctors and nurses.

How old do I need to be?

You need to be 18 years old or older. There is no specific upper age limit for taking part if you are healthy.

Do I need to have one of the mentioned cancers to join?

No, this study is specifically for healthy adults to understand how the medicine is absorbed into the body.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.